How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
28
RPRX Quote, Financials, Valuation and Earnings
Last price:
$31.11
Seasonality move
:
-2.74%
Day range:
$30.64 - $31.31
52-week range:
$24.05 - $34.20
Dividend yield:
2.71%
P/E ratio:
17.40x
P/S ratio:
8.23x
P/B ratio:
1.96x
Volume:
4.1M
Avg. volume:
4.7M
1-year change:
3.29%
Market cap:
$13.6B
Revenue:
$2.3B
EPS (TTM):
$1.80
RPRX Analysts' Consensus Rating
The 6 analysts providing 12-month price projections for Royalty Pharma PLC shares anticipate an average target of $40.92, ranging from a low estimate of $30.14 to a high estimate of $48.00. This average target implies a growth of 30.44% compared to the current stock price of $31.37.
Consensus Price Target
$40.92
Highest Price Target
$48.00
Lowest Price Target
$30.14
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 5 | 5 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | -- | Buy | Buy |
RPRX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
